Emerging synthetic strategies and pharmacological insights of 1,3,4-thiadiazole derivatives: a comprehensive review

Papers of special note have been highlighted as: • of interest

References

• 1. Serban G, Stanasel O, Serban E, Bota S. 2-Amino-1,3,4-thiadiazole as a potential scaffold for promising antimicrobial agents. Drug Des. Devel. Ther. 12, 1545–1566 (2018).
  Medline CASGoogle Scholar
• 2. Hu Y, Li CY, Wang XM, Yang YH, Zhu HL. 1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. Chem. Rev. 114(10), 5572–5610 (2014). • The article presents the detailed view of various aspects of 1,3,4-thiadiazole and its derivatives.
  Medline CASGoogle Scholar
• 3. Kumar D, Kumar V, Mundlia J, Pradhan D, Malik S. Thiazolidin-4-one derivatives as central nervous system potential agents. Cent. Nerv. Syst. Agents Med. Chem. doi: 10.2174/1871524915666150223121951 (2015) (Epub ahead of print).
  Google Scholar
• 4. Kumar H, Kumar D, Kumar P, Gupta Marwaha M, Shankar U, Kumar Marwaha R. 5-(4-(3-(substituted aryl/alkyl)-4-oxothiazolidin-2-yl)benzylidene)thiazolidine-2,4-dione molecules: synthesis, biological potential and in silico studies. doi: 10.21203/rs.3.rs-1652194/v1 (2022) (Epub ahead of print).
  Google Scholar
• 5. Chaudhari PJ, Bari SB, Surana SJ et al. Discovery and anticancer activity of novel 1,3,4-thiadiazole- and aziridine-based indolin-2-ones via in silico design followed by supramolecular green synthesis. ACS Omega 7, 17270–17294 (2022).
  Medline CASGoogle Scholar
• 6. Kumar D, Kumar H, Kumar V et al. Mechanism-based approaches of 1,3,4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity. Med. Drug Discov. 17, 100150 (2023).
  CASGoogle Scholar
• 7. Hatami M, Basri Z, Sakhvidi BK, Mortazavi M. Thiadiazole – a promising structure in design and development of anti-Alzheimer agents. Int. Immunopharmacol. 118, 110027 (2023).
  Medline CASGoogle Scholar
• 8. Atmaram UA, Roopan SM. Biological activity of oxadiazole and thiadiazole derivatives. Appl. Microbiol. Biotechnol. 106(9–10), 3489–3505 (2022).
  Medline CASGoogle Scholar
• 9. Han X, Yu YL, Hu YS, Liu XH. 1,3,4-thiadiazole: a privileged scaffold for drug design and development. Curr. Top. Med. Chem. 21(28), 2546–2573 (2021).
  Medline CASGoogle Scholar
• 10. Li Y, Geng J, Liu Y, Yu S, Zhao G. Thiadiazole – a promising structure in medicinal chemistry. ChemMedChem 8(1), 27–41 (2013).
  MedlineGoogle Scholar
• 11. Kumar D, Kumar V, Marwaha R, Singh G. Oxadiazole – an important bioactive scaffold for drug discovery and development process against HIV and cancer – a review. Curr. Bioact. Compd 15(3), 271–279 (2017).
  Google Scholar
• 12. Thakkar, S. S., Thakor, P, Doshi, H, Ray, A.. 1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities. Bioorganic & Medicinal Chemistry 25(15), 4064-4075 (2017).
  MedlineGoogle Scholar
• 13. Kumar D, Kumar H, Deep A, Kumar Marwaha R. An updated study of traditional medicines to the era of 1,3,4-oxadiazole derivatives for malaria treatment Corresponding to. Tradl Med. Res. 8(1), 5 (2023).
  CASGoogle Scholar
• 14. Kumar D, Kumar V, Kumar H, Deep A, Kumar R. 1,3,4-Oxadiazole as an emerging telomerase inhibitor – a promising anticancer motif. Cancer Adv. 5(0), e22018 (2022).
  Google Scholar
• 15. Abu-Melha S. Synthesis, molecular modelling, and antiproliferative activity of new thiadiazole-pyrazolotriazine and thiadiazole-pyrazolopyrimidine hybrids. Arab. J. Sci. Eng. 49, 381–401 (2023).
  Google Scholar
• 16. Anthwal T, Nain S. 1,3,4-Thiadiazole scaffold: as anti-epileptic agents. Front. Chem. 9, 671212 (2022).
  MedlineGoogle Scholar
• 17. Atmaram UA, Roopan SM. Biological activity of oxadiazole and thiadiazole derivatives. Appl. Microbiol. Biotechnol. 106(9–10), 3489–3505 (2022).
  Medline CASGoogle Scholar
• 18. Anthwal T, Paliwal S, Nain S. Diverse biological activities of 1,3,4-thiadiazole scaffold. Chemistry 4(4), 1654–1671 (2022).
  CASGoogle Scholar
• 19. Niu P, Kang J, Tian X et al. Synthesis of 2-amino-1,3,4-oxadiazoles and 2-Amino-1,3,4-thiadiazoles via sequential condensation and I2-mediated oxidative C-O/C-S bond formation. J. Organ. Chem. 80(2), 1018–1024 (2015).
  Medline CASGoogle Scholar
• 20. Kokovina TS, Gadomsky SY, Terentiev AA, Sanina NA. A Novel Approach to the Synthesis of 1,3,4-Thiadiazole-2-amine Derivatives. Molecules 26(17), 1–6 (2021).
  Google Scholar
• 21. Hipler F, Fischer RA, Müller J. Matrix-isolation pyrolysis investigation of mercapto-functionalized 1,3,4-thiadiazoles: thermal stability of thiadiazole lubricant additives. Phys. Chem. Chem. Phys. 7(5), 731–737 (2005).
  Medline CASGoogle Scholar
• 22. Utecht-Jarzyńska G, Jasiński M, Świątek K, Mlostoń G, Heimgartner H. Novel trifluoromethylated spiro-1,3,4-thiadiazoles via (3+2)-cycloadditions of 2,3-diphenylcyclopropenethione with selected in situ-generated nitrile imines derived from trifluoroacetonitrile. Heterocycles 101(1), 20 (2020).
  Google Scholar
• 23. Thomas A, Shenoy USK. A review on 1,3,4-thiadiazole as a single remedy for thousands of prescriptions. J. Global Trends Pharm. Sci. 10(4), 6913–6922 (2019).
  CASGoogle Scholar
• 24. Butler RN, Smyth GM, Mc Ardle P, Cunningham D. A new tricyclic ring and a nitrogen-sulfur analogue of the tri-pentagon bowl: cycloaddition reactions of the unstablised 1,3,4-thiadiazolium-3-methanide 1,3-dipole: steric influences on the endo-effect: substituted pyrrolo[2,1-b]-1,3,4-thiadiazole systems: azolium 1,3-dipoles. J. Chem. Soc. Perkin. 2(24), 2851–2860 (2002).
  Google Scholar
• 25. Li Y, Geng J, Liu Y, Yu S, Zhao G. Thiadiazole – a promising structure in medicinal chemistry. ChemMedChem 8(1), 27–41 (2013).
  MedlineGoogle Scholar
• 26. Jalhan S, Jindal A, Gupta A, Hemraj H. ChemInform 44(16), 199–208 (2013).
  Google Scholar
• 27. Baashen MA. Synthesis of N,N'-diacylhydrazines and their use in various synthetic transformations. Curr. Org. Chem. 25(12), 1394–1403 (2021).
  CASGoogle Scholar
• 28. Patil AM, Shinde RS, Sharma BR, Mirgane SR. Green synthesis, characterization, and biological studies of 1,3,4-thiadiazole derived schiff base complexes. Green Chem. Sustain. Technol. 1, 261–274 (2020).
  Google Scholar
• 29. Shamroukh AH, Hegab MI. A review on synthesis, therapeutic, and computational studies of substituted 1,3,4-thiadiazole derivatives. Egypt J. Chem. 63(11), 4387–4408 (2005).
  Google Scholar
• 30. Kokovina TS, Gadomsky SY, Terentiev AA, Sanina NA. A novel approach to the synthesis of 1,3,4-thiadiazole-2-amine derivatives. Molecules 26(17), 1–6 (2021).
  Google Scholar
• 31. Sharma B, Verma A, Prajapati S, Sharma UK. Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles. Int. J. Med. Chem. 2013, 1–16 (2013).
  Google Scholar
• 32. Kadi AA, Al-Abdullah ES, Shehata IA, Habib EE, Ibrahim TM, El-Emam AA. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. Eur. J. Med. Chem. 45(11), 5006–5011 (2010).
  Medline CASGoogle Scholar
• 33. Wei MX, Feng L, Li XQ, Zhou XZ, Shao ZH. Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessing γ-butenolide moiety and preliminary evaluation of in vitro anticancer activity. Eur. J. Med. Chem. 44(8), 3340–3344 (2009).
  Medline CASGoogle Scholar
• 34. Padmavathi V, Dinneswara Reddy G, Nagi Reddy S, Mahesh K. Synthesis and biological activity of 2-(bis((1,3,4-oxadiazolyl/1,3,4-thiadiazolyl)methylthio)methylene)malononitriles. Eur. J. Med. Chem. 46(4), 1367–1373 (2011).
  Medline CASGoogle Scholar
• 35. Barbosa GAD, De Aguiar AP, De Andrade G, Barbosa D, De Palermo Aguiar A. Rev. virtual quim. |Vol 11| |No. Rev. Virtual Quim. 11(3), 3–806 (2019).
  Google Scholar
• 36. Abo-Bakr AM, Hashem HE. New 1,3,4-thiadiazole derivatives: synthesis, characterization, and antimicrobial activity. J. Heterocycl. Chem. 56(3), 1038–1047 (2019).
  CASGoogle Scholar
• 37. Hu Y, Li CY, Wang XM, Yang YH, Zhu HL. 1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. Chem. Rev. 114(10), 5572–5610 (2014).
  Medline CASGoogle Scholar
• 38. Kumar A, Singh AK, Singh H et al. Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective. Pharmaceuticals 16(2), 299 (2023). • The title emphasizes the significance of nitrogen-containing heterocycles in cancer therapy from a medicinal chemistry perspective. It underscores their potential as anticancer agents, highlighting interdisciplinary research that may lead to novel therapeutic interventions against cancer.
  Medline CASGoogle Scholar
• 39. Ko E, Liu J, Perez LM, Lu G, Schaefer A, Burgess K. 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators. J. Am. Chem. Soc. 133(3), 462–477 (2014).
  Google Scholar
• 40. Jain AK, Sharma S, Vaidya A, Ravichandran V, Agrawal RK. 1,3,4-thiadiazole and its derivatives: a review on recent progress in biological activities. Chem. Biol. Drug Des. 81(5), 557–576 (2013). • The manuscript elaborates the biological activity of 1,3,4-thiadiazole and its derivatives.
  Medline CASGoogle Scholar
• 41. Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells 10(5), 1056 (2021).
  Medline CASGoogle Scholar
• 42. Kumar PR, Moore JA, Bowles KM, Rushworth SA, Moncrieff MD. Mitochondrial oxidative phosphorylation in cutaneous melanoma. Br. J. Cancer 124(1), 115–123 (2021).
  MedlineGoogle Scholar
• 43. Park JH, Pyun WY, Park HW. Cancer metabolism: phenotype, signaling and therapeutic targets. Cells 9(10), 1–31 (2020).
  CASGoogle Scholar
• 44. Haschek WM, Rousseaux CG, Wallig MA. Manifestations of toxic cell injury: cell injury/death and chemical carcinogenesis. Fundamenta. Toxicol. Pathol. 3, 9–42 (2010).
  Google Scholar
• 45. Arfin S, Jha NK, Jha SK et al. Oxidative stress in cancer cell metabolism. Antioxidants 10(5), 642 (2021).
  Medline CASGoogle Scholar
• 46. Szeliga M. Thiadiazole derivatives as anticancer agents. Pharmacol. Rep. 72(5), 1079 (2020). • The manuscript presents role of thiadiazole as anticancer.
  Medline CASGoogle Scholar
• 47. Altıntop MD, Ciftci HI, Radwan MO et al. Design, synthesis, and biological evaluation of novel 1,3,4-thiadiazole derivatives as potential antitumor agents against chronic myelogenous leukemia: striking effect of nitrothiazole moiety. Molecules 23(1), 59 (2017).
  MedlineGoogle Scholar
• 48. El-Naggar M, Sallam HA, Shaban SS et al. Design, synthesis, and molecular docking study of novel heterocycles incorporating 1,3,4-thiadiazole moiety as potential antimicrobial and anticancer agents. Molecules 24(6), 1066 (2019).
  MedlineGoogle Scholar
• 49. Chowrasia D, Karthikeyan C, Choure L et al. Synthesis, characterization and anti cancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Arab. J. Chem. 10, S2424–S2428 (2017).
  CASGoogle Scholar
• 50. Hekal MH, Farag PS, Hemdan MM, El-Sayed AA, Hassaballah AI, El-Sayed WM. New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile. RSC Adv. 13(23), 15810–15825 (2023).
  Medline CASGoogle Scholar
• 51. Brai A, Ronzini S, Riva V et al. Synthesis and antiviral activity of novel 1,3,4-thiadiazole inhibitors of DDX3X. Molecules 24(21), (2019).
  MedlineGoogle Scholar
• 52. Goma'a HAM, Ghaly MA, Abou-zeid LA, Badria FA, Shehata IA, El-Kerdawy MM. Synthesis, biological evaluation and in silico studies of 1,2,4-triazole and 1,3,4-thiadiazole derivatives as antiherpetic agents. Chem. Select 4(21), 6421–6428 (2019).
  Google Scholar
• 53. Bonafoux D, Nanthakumar S, Bandarage UK et al. Fragment-based discovery of dual JC Virus and BK virus helicase inhibitors. J. Med. Chem. 59(15), 7138–7151 (2016).
  Medline CASGoogle Scholar
• 54. Bekircan O, Danış Ö, Şahin ME, Çetin M. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. Bioorg. Chem. 118, 105493 (2022).
  Medline CASGoogle Scholar
• 55. Sağlik BN, Kaya Çavuşoğlu B, Acar Çevik U et al. Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors – design, synthesis, biological evaluation and molecular modelling. RSC Med. Chem. 11(9), 1063–1074 (2020).
  Medline CASGoogle Scholar
• 56. Tang X, Wang Z, Zhong X et al. Synthesis and biological activities of benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety. Phos., Sulfur, Silicon Relat. Elements 194(3), 241–248 (2018).
  Google Scholar
• 57. Galicia-Garcia U, Benito-Vicente A, Jebari S et al. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21(17), 1–34 (2020).
  Google Scholar
• 58. Khan AA, Rahim F, Taha M et al. New biologically dynamic hybrid pharmacophore triazinoindole-based-thiadiazole as potent α-glucosidase inhibitors: In vitro and in silico study. Int. J. Biol. Macromol. 199, 77–85 (2022).
  Medline CASGoogle Scholar
• 59. Dhameja M, Kumar H, Kurella S, Singh R, Uma A, Gupta P. Inhibition of α-glucosidase enzyme by ‘click’-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids. Future Med. Chem. 15(4), 345–363 (2023).
  CASGoogle Scholar
• 60. Alomari M, Taha M, Rahim F et al. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study. Bioorg. Chem. 108, 104638 (2021).
  Medline CASGoogle Scholar
• 61. Omar AZ, Alshaye N, Mosa TM, El-Sadany SK, Hamed EA, El-Atawy MA. Synthesis and antimicrobial activity screening of piperazines bearing N,N'-Bis(1,3,4-thiadiazole) moiety as probable enoyl-ACP reductase inhibitors. Molecules 27(12), 3698 (2022).
  Medline CASGoogle Scholar
• 62. Rashdan HRM, Abdelrahman MT, Shehadi IA, El-Tanany SS, Hemdan BA. Novel thiadiazole-based molecules as promising inhibitors of black fungi and pathogenic bacteria: in vitro antimicrobial evaluation and molecular docking studies. Molecules 27(11), 3613 (2022).
  Medline CASGoogle Scholar
• 63. Kamel MG, Sroor FM, Othman AM et al. Synthesis and biological evaluation of new 1,3,4-thiadiazole derivatives as potent antimicrobial agents. Monatsh. Chem. 153(10), 929–937 (2022).
  CASGoogle Scholar
• 64. Pan N, Liu C, Wu R, Fei Q, Wu W. Novel pyrimidine derivatives bearing a 1,3,4-thiadiazole skeleton: design, synthesis, and antifungal activity. Front. Chem. 10, 922813 (2022).
  Medline CASGoogle Scholar
• 65. Aliyu A, Idris AY, Musa AM et al. Design, synthesis and in-vivo anticonvulsant evaluation of 5-[(E)-(3,4,5-trimethoxybenzylidene) amino]-1,3,4-thiadiazole-2-thiol. Int. J. Sci. Glob. Sustain. 7(2), 8–8 (2021).
  Google Scholar
• 66. Malygin AS, Demidova MA, Skachilova SY, Shilova EV. Synthesis of a novel amide derivative of valproic acid and 1,3,4-thiadiazole with antiepileptic activity. Bull.Russian State Med. Univ. 1(1), 75–80 (2020).
  Google Scholar
• 67. Dinesh R, Dipak P, Hemant C. Synthesis and biological evaluation of some newer 1H-Benzo[b][1,5]diazepin-2(3H)-one derivatives as potential anticonvulsant agents. Pharmaceutical Sciences 28(4), 630–637 (2022).
  CASGoogle Scholar
• 68. Chandra Sekhar D, Venkata Rao DV, Tejeswara Rao A, Lav Kumar U, Jha A. Design and synthesis of 1,3,4-thiadiazole derivatives as novel anticancer and antitubercular agents. Russ. J. Gen. Chem. 89(4), 770–779 (2019).
  Google Scholar
• 69. Foroumadi A, Soltani F, Moallemzadeh-Haghighi H, Shafiee A. Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl alpha-(5-aryl-1,3,4-thiadiazole-2-ylthio)acetates. Arch. Pharm. (Weinheim) 338(2–3), 112–116 (2005).
  Medline CASGoogle Scholar
• 70. Kulshreshtha A, Piplani P. Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction. Eur. J. Med. Chem. 122, 557–573 (2016).
  Medline CASGoogle Scholar
• 71. Jakovljević K, Joksović MD, Matić IZ et al. Novel 1,3,4-thiadiazole-chalcone hybrids containing catechol moiety: synthesis, antioxidant activity, cytotoxicity and DNA interaction studies. Medchemcomm 9(10), 1679–1697 (2018).
  Medline CASGoogle Scholar
• 72. Shi DH, Zhu HL, Liu YW et al. Synthesis and evaluation of 5-benzyl-1,3,4-thiadiazole derivatives as acetylcholinesterase inhibitors. J. Chem. Res. 41(11), 664–667 (2017).
  CASGoogle Scholar
• 73. Uraz M, Karakuş S, Mohsen UA, Kaplancıklı ZA, Rollas S. The synthesis and evaluation of anti-acetylcholinesterase activity of some 4(3H)-quinazolinone derivatives bearing substituted 1,3,4-thiadiazole. Marmara Pharm. J. 21(1), 96–101 (2016).
  Google Scholar
• 74. Skrzypek A, Matysiak J, Karpińska M et al. Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors. Bioorg. Chem. 107, 104617 (2021).
  Medline CASGoogle Scholar
• 75. Al-Wahaibi LH, Karthikeyan S, Blacque O et al. Structural and energetic properties of weak noncovalent interactions in two closely related 3,6-disubstituted-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives: in vitro cyclooxygenase activity, crystallography, and computational investigations. ACS Omega 7(38), 34506–34520 (2022).
  Medline CASGoogle Scholar
• 76. Karki SS, Rana V, Sivan RU et al. Synthesis and antiinflammatory activity of some imidazo[2,1-b][1,3,4]thiadiazole derivatives. Acta Pol. Pharm. 72(5), 931–936 (2015).
  Medline CASGoogle Scholar
• 77. Tehrani KHME, Sardari S, Mashayekhi V, Zadeh ME, Azerang P, Kobarfard F. One pot synthesis and biological activity evaluation of novel schiff bases derived from 2-hydrazinyl-1,3,4-thiadiazole. Chem. Pharm. Bull. (Tokyo) 61(2), 160–166 (2013).
  Medline CASGoogle Scholar
• 78. Swain B, Aashritha K, Singh P et al. Design and synthesis of benzenesulfonamide-linked imidazo[2,1-b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors. Arch. Pharm. (Weinheim) 354(7), 2100028 (2021).
  CASGoogle Scholar
• 79. Seo HJ, Kim MJ, Song KS et al. Methylsulfonylpyrazolyl oxadiazoles and thiadiazoles as potent, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity. Future Med. Chem. 1(5), 947–967 (2009).
  CASGoogle Scholar